Name
BioBalt Holding OÜ
Registry code
11393103
VAT number
EE101155126
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.05.2007 (17)
Financial year
01.01-31.12
Capital
150 000.00 €
Activity
47991 - Other retail sale not in stores, stalls or markets 77401 - Leasing of intellectual property and similar products, except copyrighted works
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Antonio Chiesi 02.01.1959 (65) | 38% - 57 090.00 EUR | Board member | Direct ownership | |
Ene Talpsep 25.03.1953 (71) | 13% - 19 075.00 EUR | - | - | |
Silva Maasing 17.05.1969 (55) | 12% - 17 505.00 EUR | Board member | - | Founder |
Tiit Talpsep 22.01.1954 (70) | - | - | - | Founder |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Finbiotech Estonia OÜ 14653496 | - | - | - | Founder |
HansaBioMed Life Sciences OÜ 12993514 | - | - | - | Founder |
2019 06.07.2020 | 2020 17.08.2021 | 2021 05.07.2022 | 2022 17.07.2023 | |
---|---|---|---|---|
Total Revenue | 417 € | 0 € | 0 € | 0 € |
Net profit (loss) for the period | -29 080 € | 5 € | -84 € | -87 € |
Profit Margin | -6974% | - | - | - |
Current Assets | 74 017 € | 51 146 € | 51 061 € | 50 974 € |
Fixed Assets | 320 021 € | 320 021 € | 320 021 € | 320 021 € |
Total Assets | 394 038 € | 371 167 € | 371 082 € | 370 995 € |
Current Liabilities | 32 783 € | 9 907 € | 77 € | 3 € |
Non Current Liabilities | - | - | - | - |
Total Liabilities | - | - | - | - |
Share Capital | - | - | - | - |
Equity | 361 255 € | 361 260 € | 371 005 € | 370 992 € |
Employees | 1 | 0 | 0 | 0 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | - | - | - |
2023 Q4 | - | - | - | - |
2023 Q3 | - | - | - | - |
2023 Q2 | - | - | - | - |
2023 Q1 | - | - | - | 1 |
2022 Q4 | - | - | - | 1 |
2022 Q3 | - | - | - | 1 |
2022 Q2 | - | - | - | 1 |
2022 Q1 | - | - | - | 1 |
2021 Q4 | - | - | - | 1 |
2021 Q3 | - | - | - | 1 |
2021 Q2 | 66 € | - | - | 1 |
2021 Q1 | - | - | - | 4 |
2020 Q4 | - | - | - | 4 |
2020 Q3 | - | - | - | 4 |
2020 Q2 | 66 € | 4 797.08 € | 5 091.22 € | 4 |
2020 Q1 | - | 721.19 € | 754.04 € | 4 |